Sihuan Pharmaceutical Holdings Group Ltd. (HKG:0460)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
1.150
-0.050 (-4.17%)
May 12, 2026, 4:08 PM HKT

Revenue by Segment

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
Generic Medicine
1.40B1.97B2.60B2.20B-
Generic Medicine Growth
-29.01%-24.16%18.19%--
Innovative Medicine and Other Medicine
36.77M165.71M105.11M452.61M-
Innovative Medicine and Other Medicine Growth
-77.81%57.65%-76.78%--
Medical Aesthetic Products
449.91M149.78M398.95M26.87M-
Medical Aesthetic Products Growth
200.38%-62.46%1384.92%--
Elimination of Intersegment Sales
-24.99M-104.80M-63.81M-213.44M-
Research and Development & The Manufacture and Sale of Pharmaceutical Products
----2.88B
Research and Development & The Manufacture and Sale of Pharmaceutical Products Growth
-----1.34%
Total
1.86B2.18B3.04B2.46B2.88B
Total Growth
-14.70%-28.21%23.30%-14.39%-1.34%

Revenue by Geography

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
Mainland China
1.85B2.17B3.04B2.46B2.88B
Mainland China Growth
-14.77%-28.69%23.30%-14.39%-1.34%
United States of America
13.79M14.41M---
United States of America Growth
-4.28%----
Total
1.86B2.18B3.04B2.46B2.88B
Total Growth
-14.70%-28.21%23.30%-14.39%-1.34%
Source: S&P Global Market Intelligence.